Vitex agnus castus as prophylaxis for osteopenia after orchidectomy in rats compared with estradiol and testosterone

S Sehmisch1, J Boeckhoff, J Wille

  • 1Department of Trauma and Reconstructive Surgery, Georg-August-University of Goettingen, Goettingen, Germany. stephan.sehmisch@med.uni-goettingen.de

Phytotherapy Research : PTR
|December 25, 2008
PubMed

Insights

Vitex agnus castus (VAC) shows significant osteoprotective effects in male rats, preserving both cortical and trabecular bone. This phytoestrogen may offer a safe alternative for osteoporosis prophylaxis and hormone replacement therapy in males.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Pharmacology

Background:

  • Osteoporosis research in males is limited, with few therapeutic options available.
  • Phytoestrogens are being explored as potential prophylactic agents due to their safety profile.

Purpose of the Study:

  • To investigate the osteoprotective effects of Vitex agnus castus (VAC) in an orchidectomized male rat model.
  • To compare the effects of VAC with estradiol and testosterone supplementation on bone health.

Main Methods:

  • Sixty 3-month-old male rats underwent orchidectomy and were divided into five groups: control (soy-free diet), estradiol, testosterone, and two concentrations of VAC (high/low).
  • Treatment lasted 12 weeks, followed by biomechanical and histomorphometric testing of the tibia metaphysis.

Main Results:

  • The high-dose VAC group exhibited 87% of the biomechanical values seen with estradiol and was significantly better than the control.
  • VAC preserved cortical bone parameters similarly to the control group, unlike estradiol and testosterone which reduced cortical bone.
  • The high-dose VAC group showed substantial preservation of trabecular bone area, number, and nodes compared to estradiol.

Conclusions:

  • Vitex agnus castus demonstrates significant osteoprotective effects in males, preserving both cortical and trabecular bone.
  • VAC may serve as a safe alternative for hormone replacement therapy (HRT) in males.
  • Testosterone supplementation positively impacts trabecular bone but is counteracted by cortical bone loss.

Related Concept Videos